Lim, Yun-Ping <br/><br/>
Pregnane X receptor polymorphism affects CYP3A4 induction via a ligand-dependent interaction with steroid receptor coactivator-1.  [electronic resource] 

 -  Pharmacogenetics and genomics  May 2007 
 - 369-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1744-6872 
<br/><br/><label>Standard No.: </label>10.1097/FPC.0b013e32803e40d7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Cell Line, Tumor<br/>Chromatography, Affinity<br/>Clotrimazole--pharmacology<br/>Cytochrome P-450 CYP3A<br/>Cytochrome P-450 Enzyme System--metabolism<br/>Electrophoretic Mobility Shift Assay<br/>Enzyme Inhibitors--pharmacology<br/>Growth Inhibitors--pharmacology<br/>Histone Acetyltransferases--metabolism<br/>Humans<br/>Immunoprecipitation<br/>Ligands<br/>Mutagenesis, Site-Directed<br/>Mutation--genetics<br/>Nuclear Receptor Coactivator 1<br/>Paclitaxel--pharmacology<br/>Plasmids<br/>Polymorphism, Genetic<br/>Pregnane X Receptor<br/>Receptors, Steroid--genetics<br/>Rifampin--pharmacology<br/>Transcription Factors--metabolism<br/>Transcriptional Activation<br/>Two-Hybrid System Techniques